Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
762.7 USD | +1.13% | +3.85% | +30.83% |
Mar. 18 | AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers | RE |
Mar. 15 | Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time | RE |
- Stock
- Equities
- Stock Eli Lilly and Company - Nyse
- News Eli Lilly and Company